We’d love to hear your feedback on this activity. It helps us to continually improve our products.
WCO-IOF-ESCEO took place between 4-7 May and brought all of the latest clinical findings and advances in osteoporosis, osteoarthritis and musculoskeletal diseases. We were delighted to talk with Editorial Board member Prof. Nicholas Fuggle (MRC Life Force Epidemiology Centre, University of Southampton, UK) around his personal highlights from this year’s conference and the most promising […]
Novel oral bisphosphonate formulations have been developed to address poor adherence to conventional bisphosphonates associated with the difficulty and inflexibility of dosing in osteoporosis preventative treatment. We were delighted to talk with Editorial Board member Prof. Nicholas Fuggle (MRC Life Force Epidemiology Centre, University of Southampton, UK) to discuss the novel oral bisphosphonates, buffered effervescent […]
A digital tool for self management in osteoporosis has recently been developed to reach older patients in their own homes using the Amazon Alexa app, to improve patient adherence and outcomes. touchIMMUNOLOGY caught up with Dr. David Scott (Deakin University, Melbourne, Australia) to discuss how eHealth will support patients in self-management, how this novel technological […]
Platelet Rich Plasma (PRP) therapy uses growth factors and cytokines in platelets to repair damaged cartilage, tendons, ligaments, muscle and bone. touchIMMUNOLOGY were delighted to speak with Professor Jean-François Kaux (University of Liège, Liège, Belgium) to discuss the clinical evidence supporting the use of PRP in tendinopathies, where PRP fits into the treatment paradigm and […]
Osteoarthritis is a degenerative disease of the joints resulting in pain, stiffness and an increased fracture risk in patients, the treatment paradigm has many unmet needs in terms of preventing progression, with anti-osteoporosis drugs failing to meet endpoints in clinical trials. touchIMMUNOLOGY caught up with Dr. Nancy Lane (University of California at Davis School of […]
In this study a machine-learning approach was investigated over two years to determine the efficacy of fracture risk prediction in osteoporosis. touchIMMUNOLOGY were delighted to speak with Dr. Giovanni Adami (University of Verona, Verona, Italy) to discuss the machine-learning models already available for screening osteoporosis and their limitations, the risk factors used as predictors of […]
Osteoporosis is often underdiagnosed and undertreated with difficulties in patient adherence to medication due to lack of symptoms until fracture. We were delighted to talk with Dr. Patricia Khashayar (Ghent University, Gent, Belgium) to discuss how rapid results from PoCOsteo will impact patient compliance and outcomes. The abstract ‘POCOSTEO: RAPID, COST-EFFECTIVE AND EASY-TO-USE POINT-OF-CARE (POC) […]
PoCOsteo is a point-of-care tool that provides rapid genomic and proteomic analysis of the blood for the early detection and management of osteoporosis. It was a pleasure to talk with Dr. Patricia Khashayar (Ghent University, Gent, Belgium) to discuss the importance of the early detection of osteoporosis in management, the overall objective of the PoCOsteo […]
We were delighted to talk with Dr. Nicholas Fuggle (the University of Southampton, Southampton, UK) around the unmet needs and the burden of hand osteoarthritis for patients and how patient outcomes can be improved in the future. ‘Management of hand osteoarthritis: what really matters for the patient’ was presented at WCO IOF-ESCEO 2022, 24-26 March, […]
Get the latest clinical insights from touchIMMUNOLOGY